NCT02626013View on ClinicalTrials.gov

Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece

CompletedOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

April 12, 2016

Primary Completion Date

September 12, 2018

Study Completion Date

September 12, 2018

Conditions
Metastatic Breast Cancer
Trial Locations (1)

GR11528

Athens, Athens

Sponsors
All Listed Sponsors
lead

Genesis Pharma S.A.

INDUSTRY

NCT02626013 - Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece | Biotech Hunter | Biotech Hunter